IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.
Rubino V, Hüppi M, Höpner S, Tortola L, Schnüriger N, Legenne H, Taylor L, Voggensperger S, Keller I, Bruggman R, Kronig MN, Bacher U, Kopf M, Ochsenbein AF, Riether C.
Rubino V, et al. Among authors: kronig mn.
Cell Rep Med. 2024 Nov 19;5(11):101826. doi: 10.1016/j.xcrm.2024.101826. Epub 2024 Nov 12.
Cell Rep Med. 2024.
PMID: 39536753
Free PMC article.